Clinical Trial Update: A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the combination of semaglutide and empagliflozin with automated insulin delivery to improve diabetes control in adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• semaglutide (semaglutide)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Diabetes Type 1 | Phase 3 | Status: RECRUITING